Metabolic conditions

Latest articles

Recent research has found that the gut microbiota may play an important role not only in the development of type 2 diabetes mellitus (T2DM), but also the therapeutic actions of the widely prescribed antidiabetic drug metformin. Although dietary fiber has documented effects on preventing T2DM and improving glucose metabolism in diabetic individuals, little is known about whether prebiotics could have…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Recent research has found that the gut microbiota may play an important role not only in the development of type 2 diabetes mellitus (T2DM), but also the therapeutic actions of the widely prescribed antidiabetic drug metformin. Although dietary fiber has documented effects on preventing T2DM and improving glucose metabolism in diabetic individuals, little is known about whether prebiotics could have…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Hepatic steatosis is a multifactorial condition related to obesity that may contribute to the development of virus-associated and non-alcoholic fatty liver disease (NAFLD) in humans, in which patients usually start to show symptoms when the disease is in its advanced stages. Although the gut microbiome has recently evolved as a new and important player in the pathophysiology of liver diseases,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Hepatic steatosis is a multifactorial condition related to obesity that may contribute to the development of virus-associated and non-alcoholic fatty liver disease (NAFLD) in humans, in which patients usually start to show symptoms when the disease is in its advanced stages. Although the gut microbiome has recently evolved as a new and important player in the pathophysiology of liver diseases,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Arterial stiffness—defined as the reduced capability of an artery to expand and contract in response to pressure changes—has been previously reported as an independent predictor of major adverse cardiovascular events in individuals with metabolic syndrome. However, it is poorly associated with traditional cardiovascular risk factors, including hyperlipidemia, diabetes mellitus, obesity and smoking. Furthermore, we do not know whether gut microbiome…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Arterial stiffness—defined as the reduced capability of an artery to expand and contract in response to pressure changes—has been previously reported as an independent predictor of major adverse cardiovascular events in individuals with metabolic syndrome. However, it is poorly associated with traditional cardiovascular risk factors, including hyperlipidemia, diabetes mellitus, obesity and smoking. Furthermore, we do not know whether gut microbiome…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

New developments in genetics and metagenomics over the past 15 years have led scientists to produce an in-depth characterization of the composition and function of the gut microbiome as a novel organ in the close intersection between health and disease. As a result, the number of publications discussing the gut microbiota over the past five years represents more than 80%…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

New developments in genetics and metagenomics over the past 15 years have led scientists to produce an in-depth characterization of the composition and function of the gut microbiome as a novel organ in the close intersection between health and disease. As a result, the number of publications discussing the gut microbiota over the past five years represents more than 80%…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.
Twitter
News archive
Access from here to the chronological archive of news of this site
Access archive
Latest articles

Recent research has found that the gut microbiota may play an important role not only in the development of type 2 diabetes mellitus (T2DM), but also the therapeutic actions of the widely prescribed antidiabetic drug…

Hepatic steatosis is a multifactorial condition related to obesity that may contribute to the development of virus-associated and non-alcoholic fatty liver disease (NAFLD) in humans, in which patients usually start to show symptoms when the…

Arterial stiffness—defined as the reduced capability of an artery to expand and contract in response to pressure changes—has been previously reported as an independent predictor of major adverse cardiovascular events in individuals with metabolic syndrome.…

New developments in genetics and metagenomics over the past 15 years have led scientists to produce an in-depth characterization of the composition and function of the gut microbiome as a novel organ in the close…